May 19, 2021
A new bioresorbable scaffold (Firesorb, MicroPort Medical), one with much thinner struts compared with first-generation “dissolving” devices, has shown some early promise in a study of patients with relatively simple coronary artery lesions.
Presenting the results of FUTURE II as a late-breaking clinical trial at EuroPCR, Bo Xu, MBBS (National Clinical Research Center for Cardiovascular Disease/Peking Union Medical College, Beijing, China), reported that in this trial, which included operators adhering to a dedicated implantation technique, the bioresorbable scaffold was noninferior to a cobalt-chromium everolimus-eluting stent (Xience; Abbott Vascular) for the primary endpoint of in-segment late lumen loss.
While FUTURE II is a small study looking solely at angiographic outcomes, Xu said he remains optimistic about the technology. “I think, although this is a very small sized study with angiographic outcomes is comparing a new device with a drug-eluting ste
Breaking the cycle
Promoting better menstrual literacy will help clinicians assess and manage the symptoms associated with dysmenorrhea, according to a new Irish study.
Peter Doyle reports
More needs to be done to remove the stigma surrounding menstruation and menstrual pain, an award-winning Irish research paper is reporting.
Defined as cramping pain in the lower abdomen occurring just before or during menstruation, menstrual pain, also known as primary dysmenorrhea (PD), affects the majority of women of reproductive age.
Researchers from Centre for Pain Research, National University of Ireland Galway (NUIG), and the NUIG’s School of Psychology recently investigated the impact the condition was having on third-level students.
Research to explore farm-supplied alternative AD feedstock | Bioenergy Insight Magazine bioenergy-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioenergy-news.com Daily Mail and Mail on Sunday newspapers.
Study proposes new protocol for treating cardiac arrhythmias with radio frequency energy and catheterization
An article published in
International Journal of Hyperthermia proposes a more effective protocol for the treatment of cardiac arrhythmias when applying radiofrequency energy at the site of the arrhythmia by catheterization.
The research results from the final year project (TFG) on the bachelor s degree in Biomedical Engineering by Sergi Coderch Navarro, supervised by Ana González Suárez and Oscar Camara, researchers with the PhySense group of the BCN MedTech Research Unit at the UPF Department of Information and Communication Technologies (DTIC).
Sergi Coderch Navarro defended his TFG in July 2019 and was a runner-up in the 2019 Gemma Rossell i Romero Awards. Currently, Ana González Suárez is a postdoctoral researcher at the Translational Medical Device Lab (University College Hospital Galway) within the National University of Ireland Galway.
E-Mail
IMAGE: Temperature distribution (°C) and thermal lesions created in cardiac tissue with the catheter in the parallel orientation by a standard ablation protocol of 20?W-45?s (A) and 30?W-30?s (B), and also. view more
Credit: Sergi Coderch
An article published in
International Journal of Hyperthermia proposes a more effective protocol for the treatment of cardiac arrhythmias when applying radiofrequency energy at the site of the arrhythmia by catheterization. The research results from the final year project (TFG) on the bachelor s degree in Biomedical Engineering by Sergi Coderch Navarro, supervised by Ana González Suárez and Oscar Camara, researchers with the PhySense group of the BCN MedTech Research Unit at the UPF Department of Information and Communication Technologies (DTIC). Sergi Coderch Navarro defended his TFG in July 2019 and was a runner-up in the 2019 Gemma Rossell i Romero Awards. Currently, Ana González Suárez is a postdoctoral researcher a